Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.
At the risk of turning this into the “Week in Oklahoma Weed,” here’s the latest on what happening in the Sooner State.
- Signatures submitted for Oklahoma recreational marijuana ballot measure
(Marijuana Business Daily: News, 10 August 2018)
A group that wants to legalize recreational marijuana in Oklahoma has submitted signatures to qualify the measure for a statewide vote after saying it may not have enough to qualify for the November ballot.
And for further proof it’s not just the coasts that are thinking of legalizing recreational cannabis, we have this news from the Upper Midwest.
- North Dakota to vote on legalizing marijuana for recreational use in November
(United Press International: Latest News, 14 August 2018)
North Dakota will vote on whether to legalize marijuana for recreational use after a measure was approved for the November ballot on Monday.
- North Dakota to vote on recreational marijuana in November
(The Hill: News, 14 August 2018)
North Dakotans will vote this November on a ballot measure to legalize recreational marijuana, state officials announced Monday.
You will doubtless recall that the FDA approved a CBD medication recently. We now know what the price tag will be.
- First FDA-Approved CBD Medication to Cost More than $32,000 Per Year
(Ganjapreneur, 10 August 2018)
GW Pharmaceuticals has revealed the expected consumer price for Epidiolex, the first cannabidiol-based medication to be approved by the FDA, according to a Business Insider report.